Citius Oncology Inc (CTOR)

$1.75 +0.06 (3.55%)
Market Cap 132.45M
Revenue (ttm) 0.00
Net Income (ttm) -21.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.25
Volume 103,600
Avg Vol 2,392,858
Day's Range N/A - N/A
Shares Out 78.37M
Stochastic %K 31%
Beta 3.00
Analysts Hold
Price Target $3.00

Company Profile

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: (908) 967-6677
Address:
11 Commerce Drive, First Floor, Cranford, United States
SweStonk
SweStonk Aug. 18 at 7:08 PM
$CTOR
0 · Reply
SweStonk
SweStonk Aug. 14 at 8:13 PM
$CTOR 6 years delay on ML and counting. How many delays for this turd? 1 year and counting? See yah in 6 years 😂
2 · Reply
Marcos211
Marcos211 Aug. 13 at 8:12 PM
Watchers and Volume are picking up rapidly on ticker MTEX ! This could be the next multi - day runner! MTEX moves like a true nano nano floater! Show me some 100K buying candles and this could HALT UP and spike to 15+$ Some will buy now some will chase later! $GSIW $ORIS $LCFY $CTOR !!!!
0 · Reply
SKEETER_1
SKEETER_1 Aug. 13 at 2:28 PM
$CTXR $CTOR the only reason he made this payment on paper is because he believes this will eventually end up it in court, and the prosecutor can nonlonger claim 'no intention to pay'.
1 · Reply
TwongStocks
TwongStocks Aug. 12 at 10:24 PM
$CTXR $CTOR Missed this part, but they also made a dent into what they owe Reddy for teh approval milestone. As of June 30, they owed Reddy a balance of $22.5m • On July 10, CTXR paid $1M. • On Jul 28, CTXR made a payment of $1.25m With those payments, their balance to Reddy is now $20.25.
2 · Reply
TwongStocks
TwongStocks Aug. 12 at 9:47 PM
$CTOR $CTXR In CTOR's 10-Q, they confirm that the first repayment to Eisai was made in July. • CTXR paid $1,091,167.12 on July 15 for outstanding milestone approval fee and accumulated interest. • CTOR paid $1,616,521.96 on July 21 certain other invoices and accumulated interest. • Combined payment of $2,707,689.08 Next payment is due Aug 15, $2.35m.
0 · Reply
TradeWarriorXXL
TradeWarriorXXL Aug. 12 at 9:04 PM
$CTOR I told you all earlier today about $CGTX when it was .84 and now it is $1.27. Look into $CGTX and do your DD!
0 · Reply
TwongStocks
TwongStocks Aug. 12 at 8:43 PM
$CTXR $CTOR ER summary • Lymphir launch expected Q4 2025 • "After giving effect to the July 17, 2025 financing by Citius Oncology, we expect that we will have sufficient funds to continue our operations through September 2025. " • ATM use: During the three months ended June 30, 2025, CTXR sold 2,185,249 shares for gross proceeds of $3,471,866. CTXR had $6.1m in cash and CTOR had $112 in cash as of June 30. This does not include the net proceeds of $7.4m that CTOR received from the July offering. CTXR confirmed that after June 30, 2.45m of the pre-funded warrants from the June offering were exercised. Full summary, with links to the ERs and 10-Qs --> https://www.reddit.com/r/CTXR/comments/1mokb22/ctxr_and_ctor_release_financial_results_and/
2 · Reply
tsj555
tsj555 Aug. 12 at 2:22 PM
$CTOR some green finally
1 · Reply
TradeWarriorXXL
TradeWarriorXXL Aug. 12 at 1:15 PM
$CGTX I'm so happy that I moved from $CTOR right before the big drop and came here earlier in July. This one has all of the fundamentals necessary for big moves. Multiple catalysts are coming and great results already. $CGTX has incredible upside. Already up 45% since I went almost all in.
2 · Reply
Latest News on CTOR
Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update

Aug 12, 2025, 4:30 PM EDT - 6 days ago

Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update

Citius Oncology Announces Closing of $9.0 Million Public Offering

Jul 17, 2025, 4:30 PM EDT - 4 weeks ago

Citius Oncology Announces Closing of $9.0 Million Public Offering

CTXR

Citius Oncology Announces Pricing of $9.0 Million Public Offering

Jul 16, 2025, 9:15 AM EDT - 4 weeks ago

Citius Oncology Announces Pricing of $9.0 Million Public Offering

CTXR

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora

Jul 15, 2025, 8:32 AM EDT - 4 weeks ago

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora

CTXR

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025

Jun 17, 2025, 8:08 AM EDT - 2 months ago

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025

CTXR

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update

May 14, 2025, 4:30 PM EDT - 3 months ago

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

May 5, 2025, 8:37 AM EDT - 3 months ago

Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

CTXR

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Feb 14, 2025, 4:30 PM EST - 6 months ago

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

CTXR

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Feb 14, 2025, 4:30 PM EST - 6 months ago

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

Feb 6, 2025, 8:55 AM EST - 6 months ago

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

CTXR

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

Jan 7, 2025, 8:08 AM EST - 7 months ago

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

CTXR

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

Jan 6, 2025, 7:50 AM EST - 8 months ago

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

CTXR

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Dec 27, 2024, 5:00 PM EST - 8 months ago

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

SweStonk
SweStonk Aug. 18 at 7:08 PM
$CTOR
0 · Reply
SweStonk
SweStonk Aug. 14 at 8:13 PM
$CTOR 6 years delay on ML and counting. How many delays for this turd? 1 year and counting? See yah in 6 years 😂
2 · Reply
Marcos211
Marcos211 Aug. 13 at 8:12 PM
Watchers and Volume are picking up rapidly on ticker MTEX ! This could be the next multi - day runner! MTEX moves like a true nano nano floater! Show me some 100K buying candles and this could HALT UP and spike to 15+$ Some will buy now some will chase later! $GSIW $ORIS $LCFY $CTOR !!!!
0 · Reply
SKEETER_1
SKEETER_1 Aug. 13 at 2:28 PM
$CTXR $CTOR the only reason he made this payment on paper is because he believes this will eventually end up it in court, and the prosecutor can nonlonger claim 'no intention to pay'.
1 · Reply
TwongStocks
TwongStocks Aug. 12 at 10:24 PM
$CTXR $CTOR Missed this part, but they also made a dent into what they owe Reddy for teh approval milestone. As of June 30, they owed Reddy a balance of $22.5m • On July 10, CTXR paid $1M. • On Jul 28, CTXR made a payment of $1.25m With those payments, their balance to Reddy is now $20.25.
2 · Reply
TwongStocks
TwongStocks Aug. 12 at 9:47 PM
$CTOR $CTXR In CTOR's 10-Q, they confirm that the first repayment to Eisai was made in July. • CTXR paid $1,091,167.12 on July 15 for outstanding milestone approval fee and accumulated interest. • CTOR paid $1,616,521.96 on July 21 certain other invoices and accumulated interest. • Combined payment of $2,707,689.08 Next payment is due Aug 15, $2.35m.
0 · Reply
TradeWarriorXXL
TradeWarriorXXL Aug. 12 at 9:04 PM
$CTOR I told you all earlier today about $CGTX when it was .84 and now it is $1.27. Look into $CGTX and do your DD!
0 · Reply
TwongStocks
TwongStocks Aug. 12 at 8:43 PM
$CTXR $CTOR ER summary • Lymphir launch expected Q4 2025 • "After giving effect to the July 17, 2025 financing by Citius Oncology, we expect that we will have sufficient funds to continue our operations through September 2025. " • ATM use: During the three months ended June 30, 2025, CTXR sold 2,185,249 shares for gross proceeds of $3,471,866. CTXR had $6.1m in cash and CTOR had $112 in cash as of June 30. This does not include the net proceeds of $7.4m that CTOR received from the July offering. CTXR confirmed that after June 30, 2.45m of the pre-funded warrants from the June offering were exercised. Full summary, with links to the ERs and 10-Qs --> https://www.reddit.com/r/CTXR/comments/1mokb22/ctxr_and_ctor_release_financial_results_and/
2 · Reply
tsj555
tsj555 Aug. 12 at 2:22 PM
$CTOR some green finally
1 · Reply
TradeWarriorXXL
TradeWarriorXXL Aug. 12 at 1:15 PM
$CGTX I'm so happy that I moved from $CTOR right before the big drop and came here earlier in July. This one has all of the fundamentals necessary for big moves. Multiple catalysts are coming and great results already. $CGTX has incredible upside. Already up 45% since I went almost all in.
2 · Reply
SweStonk
SweStonk Aug. 11 at 7:11 PM
$CTOR where is that run to $5 bulls kept talking about? 4b market 😂 They be lucky to earn $10M/year
1 · Reply
TwongStocks
TwongStocks Aug. 11 at 1:08 PM
$CTOR $CTXR Previous qtr ended on June 30. The SEC's 10-Q filing deadline for non-accelerated filers is Thursday Aug 14. Should see the ER from both companies this week.
0 · Reply
JoseGilberto109
JoseGilberto109 Aug. 8 at 11:18 PM
Wow what is happening to SNSE right now!? Seems like ALL volume and momentum are shifting into SNSE!! Could it be the next crazy runner of the day?? Only 500k float on SNSE - Bulls should keep it on watch!! Also watching: $LCFY $NXTT $WHLR $CTOR $CTXR news coming
0 · Reply
tsj555
tsj555 Aug. 8 at 6:27 PM
$CTOR
0 · Reply
Cheriebomb
Cheriebomb Aug. 7 at 11:07 PM
$CTOR Glad I left with a lil profit.
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 6 at 1:02 PM
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators $SNGX $AMGN $FOLD $TNXP $CTOR https://ibn.fm/x9cai
1 · Reply
donein12
donein12 Aug. 6 at 12:53 PM
$CTOR A PR Article that mentions CTOR. Nothing shareholders didn'y know. Only signed contracts really will push the price, but nice exposure anyway: https://investorshub.advfn.com/stock-market/NASDAQ/citius-oncology-CTOR/stock-news/96575081/clinical-progress-in-rare-disease-signals-long-ter
0 · Reply
SweStonk
SweStonk Aug. 6 at 12:10 PM
$CTOR wen launch? 2027?😂
0 · Reply
donein12
donein12 Aug. 5 at 3:56 PM
$CTOR My guess CTOR starts to head up back to $2 from here.
0 · Reply
donein12
donein12 Aug. 5 at 1:13 PM
$CTOR One NEW institutional investor just filed on 8/4/2025 their holdings bought in CTOR for the 2nd qtr. of 2025. Owner Name Arkadios Wealth Advisors Date 6/30/2025 Shares Held 11,666 Change (Shares)11,666 NEW LINK #1 --Click on NEW https://www.nasdaq.com/market-activity/stocks/ctor/institutional-holdings?page=1&rows_per_page=10 Link:#2 https://www.sec.gov/cgi-bin/browse-edgar?filenum=028-20081&action=getcompany
0 · Reply
Benjamin2020
Benjamin2020 Aug. 4 at 8:44 PM
$CTOR wen news 😝
0 · Reply
Worknpaint
Worknpaint Aug. 3 at 1:18 PM
$CTOR Partner/buyout?Merk? Maybe?
1 · Reply